Krystyna Dabrowska
Overview
Explore the profile of Krystyna Dabrowska including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
82
Citations
2273
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gallea J, Nevskyi O, Kazmierczak Z, Gligonov I, Chen T, Miernikiewicz P, et al.
Adv Mater
. 2025 Jan;
e2403365.
PMID: 39821930
In the burgeoning field of super-resolution fluorescence microscopy, significant efforts are being dedicated to expanding its applications into the 3D domain. Various methodologies have been developed that enable isotropic resolution...
2.
Echterhof A, Dharmaraj T, Khosravi A, McBride R, Miesel L, Chia J, et al.
JCI Insight
. 2024 Oct;
9(20).
PMID: 39435664
With the increasing prevalence of antimicrobial-resistant bacterial infections, there is interest in using bacteriophages (phages) to treat such infections. However, the factors that govern bacteriophage pharmacokinetics in vivo remain poorly...
3.
Harhala M, Gembara K, Baniecki K, Pikies A, Nahorecki A, Jedruchniewicz N, et al.
Viruses
. 2024 Jan;
16(1).
PMID: 38257758
Multiple pathogens are competing against the human immune response, leading to outbreaks that are increasingly difficult to control. For example, the SARS-CoV-2 virus continually evolves, giving rise to new variants....
4.
Interaction of Bacteriophages with the Immune System: Induction of Bacteriophage-Specific Antibodies
Gembara K, Dabrowska K
Methods Mol Biol
. 2023 Dec;
2734:183-196.
PMID: 38066370
In all cases when a bacteriophage makes a direct contact with a mammalian organism, it may challenge the mammalian immunological system. Its major consequence is the production of antibodies specific...
5.
Harhala M, Gembara K, Rybicka I, Kazmierczak Z, Miernikiewicz P, Majewska J, et al.
Front Immunol
. 2023 Oct;
14:1075774.
PMID: 37781366
Bacteriolytic enzymes are promising antibacterial agents, but they can cause a typical immune response . In this study, we used a targeted modification method for two antibacterial endolysins, Pal and...
6.
Majewska J, Miernikiewicz P, Szymczak A, Kazmierczak Z, Goszczynski T, Owczarek B, et al.
Microbiol Spectr
. 2023 Sep;
:e0011523.
PMID: 37724862
Bacteriophages colonize animal and human bodies, propagating on sensitive bacteria that are symbionts, commensals, or pathogens of animals and humans. T4-like phages are dependent on abundant symbionts such as ,...
7.
Miernikiewicz P, Barylski J, Wilczak A, Dragos A, Rybicka I, Baldysz S, et al.
Cells
. 2023 Aug;
12(15).
PMID: 37566076
is an opportunistic pathogen, particularly life-threatening for the immunocompromised. It is associated with pneumonia, endocarditis, peritonitis and many other serious infections, including septicemia. Of note, produces metabolites that support and...
8.
Szewczyk-Dabrowska A, Banasik M, Dabrowska K, Kujawa K, Bombala W, Sebastian A, et al.
J Clin Med
. 2023 Feb;
12(3).
PMID: 36769525
Background: Oncology patients are a particularly vulnerable group to the severe course of COVID-19 due to, e.g., the suppression of the immune system. The study aimed to find links between...
9.
Baginska N, Harhala M, Cieslik M, Orwat F, Weber-Dabrowska B, Dabrowska K, et al.
Viruses
. 2023 Jan;
15(1).
PMID: 36680270
Infections with the opportunistic Gram-negative bacterium pose a serious threat today, which is aggravated by the growing problem of multi-drug resistance among bacteria, caused by the overuse of antibiotics. Treatment...
10.
Szewczyk-Dabrowska A, Budziar W, Harhala M, Baniecki K, Pikies A, Jedruchniewicz N, et al.
Sci Rep
. 2022 Sep;
12(1):15944.
PMID: 36153350
Predictors for the risk of severe COVID-19 are crucial for patient care and control of the disease. Other infectious diseases as potential comorbidities in SARS-CoV-2 infection are still poorly understood....